News

CardioFocus Blazes New Trails with OptiShot™ Ablation System

CardioFocus Blazes New Trails with OptiShot™ Ablation System

Innovations in Cardiac Care: The OptiShot™ System

CardioFocus, Inc. recently made headlines in the field of cardiac care by introducing the OptiShot™ Pulsed Field Ablation (PFA) System. This cutting-edge technology is specially designed to treat paroxysmal atrial fibrillation, a condition that disrupts the heart's normal rhythm. This initiative is part of the ongoing VISION AF clinical trial, aiming to advance treatment options available for patients.

First Patient Treatments Mark a Significant Milestone

The initial patients treated with the OptiShot system were part of a pioneering effort at the Na Homolce Hospital in Prague. Dr. Vivek Reddy and Professor Petr Neužil led these groundbreaking procedures, marking a hopeful step forward in the management of cardiac arrhythmias. These cases represent the start of an innovative clinical trial, anticipated to involve up to 50 patients, each undergoing treatment with a 12-month follow-up period to evaluate the system's effectiveness.

What Makes OptiShot Unique?

The OptiShot balloon catheter stands out due to its unique design, which provides endoscopic visual confirmation of electrode-tissue contact. Dr. Reddy emphasized this feature by noting his increased confidence in treatment efficacy as a result. This capability not only helps ensure more precise treatment but also aims to improve patient outcomes significantly.

The Future of Patient-Centric Treatment

Professor Neužil elaborated on the advantages of the ultra-compliant balloon featured in the OptiShot system. This design promotes adaptability across a range of patient anatomies and enhances the delivery of pulsed electric field energy, essential for effective ablation. The goal is to ultimately enhance patient recovery and improve prognoses following procedures.

Leadership Insights

CardioFocus CEO, Steve Ogilvie, expressed the company's commitment to innovation by stating, "We have merged our expertise in pulsed field technology with tried-and-true balloon systems, culminating in the development of the OptiShot system. This evolution marks a step closer to a comprehensive solution for isolated pulmonary vein treatments, ensuring safe and effective approaches for patients.”

A Broader Portfolio in Cardiac Technologies

CardioFocus is not stopping with the OptiShot system; the company is diversifying its portfolio in PFA. Alongside OptiShot, the ongoing trials for the QuickShot™ PFA System showcase CardioFocus's commitment to innovation in ablation technologies. This new catheter integrates seamlessly with various navigation systems, providing more options for patient care. In the EU, CardioFocus has successfully treated over 6,000 patients utilizing their Centauri PFA System. This system employs a sophisticated monopolar waveform and features contact-force sensing, paired with advanced mapping systems.

About CardioFocus, Inc.

Based in Marlborough, Massachusetts, CardioFocus, Inc. continues to lead the innovation of medical devices centered on ablation therapies for cardiac conditions such as atrial fibrillation. Their dedication to improving patient care integrates the latest scientific advancements with a patient-first philosophy. To learn more about their cutting-edge solutions, visit CardioFocus.com.

Frequently Asked Questions

What is the OptiShot™ Pulsed Field Ablation System?

The OptiShot system is an advanced medical device designed to treat paroxysmal atrial fibrillation using pulsed field ablation techniques.

Who conducted the first treatments with the OptiShot system?

The initial treatments were performed by Dr. Vivek Reddy and Professor Petr Neužil at Na Homolce Hospital in Prague.

How many patients will be involved in the VISION AF trial?

The clinical trial plans to treat up to 50 patients with the OptiShot system.

What is unique about the OptiShot catheter design?

The catheter provides endoscopic visual confirmation, ensuring precise electrode-tissue contact during procedures.

What other systems is CardioFocus developing?

CardioFocus is also working on the QuickShot™ PFA System and evaluates various technologies for large area focal ablation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 179

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 171

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 161

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 175

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
vVARDIS Debuts on NYSE: Transforming Dental Care

Updated Category News Views 92

A New Chapter for Dental Tech Mark your calendars, folks. vVARDIS is stepping onto the New York Stock Exchange (NYSE) stage, waving the banner of NYSE:VVVV. Now, if you've ever sat in that squeaky dental chair feeling the dread of a drill, vVARDIS might just be the new hero in town. Founded by the dynamic duo, Dr. Haley and Dr. Goly Abivardi, they're on a mission to...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 94

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 170

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading

Top 5 Most Recently Viewed Articles

Berry Global Plans Senior Secured Notes Offering Ahead of Merger

Updated Category News Views 126

Berry Global’s Strategic Offering of Senior Secured Notes In an exciting development, Berry Global Group, Inc. (NYSE:BERY) has outlined plans for the issuance of senior secured notes through its subsidiary, Treasure Escrow Corporation. This move is a crucial step in conjunction with the anticipated merger of Berry's Health, Hygiene and Specialties Global Nonwovens and...

Continue Reading
Hexaware Technologies Expands Presence with New London HQ

Updated Category News Views 260

Hexaware Technologies Expands Its Footprint with New Headquarters Hexaware Technologies, a renowned name in the realm of IT, AI, and digital services, has recently taken a significant step by inaugurating its new UK headquarters at One Canada Square, in the vibrant Canary Wharf area. This new facility is set to play a crucial role in the company’s strategy to enhance...

Continue Reading
Aroa Biosurgery Advances in Treating Venous Leg Ulcers

Updated Category News Views 343

Aroa Biosurgery Advances in Treating Venous Leg Ulcers Aroa Biosurgery, a leading name in soft tissue regeneration technology, has achieved a significant milestone in clinical evidence for their proprietary Endoform product. The company announced that over 100 peer-reviewed studies now confirm the efficacy of their AROA ECM technology in treating various wound types....

Continue Reading
Innovative Paver Spacer Designed for Perfect Alignment

Updated Category News Views 231

Revolutionizing Landscape Design with a New Paver Spacer The landscape industry is continuously evolving, and one of the most exciting innovations to recently emerge is a specialized paver spacer. This unique design addresses a common problem faced by landscapers and homeowners alike: the challenge of aligning concrete or clay pavers effectively. An inventor with a vision...

Continue Reading
Transforming Diagnostics: The Rise of Digital Pathology Market

Updated Category News Views 232

Understanding Digital Pathology Market Dynamics In recent years, the Digital Pathology Market has emerged as a key player in the healthcare sector, showing significant growth and innovation. With an expected market size of USD 2.92 billion by the end of the forecast period, the sector has captured investor interest and demonstrated the potential to reshape diagnostic...

Continue Reading